JMP Securities Upgrades Enanta Pharmaceuticals (ENTA) to Market Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
Go back to JMP Securities Upgrades Enanta Pharmaceuticals (ENTA) to Market Outperform
October 23, 2015 7:00 AM EDT
Barclays downgraded Enanta Pharmaceuticals (NASDAQ: ENTA) from Equalweight to Underweight with a price target of $16.00 (from $45.00).
For an analyst ratings summary and ratings history on Enanta Pharmaceuticals click here. For more ratings news on Enanta Pharmaceuticals click here.
Shares of Enanta Pharmaceuticals closed at $23.90 yesterday.
...
More
October 22, 2015 3:30 PM EDT
Enanta Pharma (NASDAQ: ENTA) Halted on Second LUDP
...
More
October 22, 2015 3:29 PM EDT
Enanta Pharma (NASDAQ: ENTA) shares dropped over 50% after the FDA warned of serious liver injury risk with Viekira Pak.
...
More
October 22, 2015 3:14 PM EDT
Enanta Pharma (NASDAQ: ENTA) triggers limit-up, limit-down trading pause. The activity is related to Abbvie news.
...
More
